Reuters logo
BRIEF-Beijing SL Pharmaceutical gets approval to conduct drug clinical trials for Pegaspargase Injection
December 6, 2017 / 7:48 AM / 8 days ago

BRIEF-Beijing SL Pharmaceutical gets approval to conduct drug clinical trials for Pegaspargase Injection

Dec 6 (Reuters) - Beijing SL Pharmaceutical Co Ltd :

* Says it gets approval to conduct drug clinical trials of Pegaspargase Injection which can be used for treatment of acute lymphoblastic leukemia and non-Hodgkin’s lymphoma as well as Acute myelogenous leukemia

Source text in Chinese: goo.gl/wHXz3u

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below